Who have Chronic obstructive pulmonary disease when taking Bisoprolol fumarate and Montelukast sodium - from FDA reports


Summary

Chronic obstructive pulmonary disease is reported only by a few people who take Bisoprolol fumarate and Montelukast sodium. We study 20 people who have side effects while taking Bisoprolol fumarate and Montelukast sodium from FDA. Among them, 1 have Chronic obstructive pulmonary disease. Find out below who they are, when they have Chronic obstructive pulmonary disease and more.

You are not alone!

Join a support group for people who take Bisoprolol fumarate and Montelukast sodium

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 14, 2017

20 people reported to have side effects when taking Bisoprolol fumarate and Montelukast sodium. Among them, 1 person (5.0%) has Chronic obstructive pulmonary disease


Number of reports submitted per year:

Trend of 'Chronic obstructive pulmonary disease in Bisoprolol fumarate and Montelukast sodium'

Gender of people who have chronic obstructive pulmonary disease when taking the drugs *:

  • female: 100 %
  • male: 0.0 %

Age of people who have chronic obstructive pulmonary disease when taking th drugs *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Rheumatoid Arthritis (1 person, 100.00%)
  • Gastroesophageal Reflux Disease (1 person, 100.00%)

Top co-used drugs for these people *:

  • Warfarin Sodium (1 person, 100.00%)
  • Risedronate Sodium (1 person, 100.00%)
  • Pantoprazole Sodium (1 person, 100.00%)
  • Humira (1 person, 100.00%)
  • Ezetimibe (1 person, 100.00%)

Top other side effects for these people *:

  • Upper Respiratory Tract Infection (1 person, 100.00%)
  • The Flu (1 person, 100.00%)
  • Rheumatoid Arthritis (1 person, 100.00%)
  • Pneumonia (1 person, 100.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Chronic obstructive pulmonary disease when taking Bisoprolol fumarate and Montelukast sodium?

Expand the study to include reports from both FDA and eHealthMe

Chronic obstructive pulmonary disease with Bisoprolol fumarate and Montelukast sodium from FDA and eHealthme reports

Drugs that are associated with Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease

Could your condition cause Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease

Can you answer these questions?

More questions for: Bisoprolol fumarate, Montelukast sodium, Chronic obstructive pulmonary disease

You may be interested in these reviews

More reviews for: Bisoprolol fumarate, Montelukast sodium, Chronic obstructive pulmonary disease